Video

Ken Keller's Leadership Philosophy And Future Plans

Source: Bioprocess Online

Daiichi Sankyo’s CEO Ken Keller explains how the oncology division grew from five to over 2,000 people and what’s next for the company’s ADC pipeline.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: